Literature DB >> 7771566

Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts.

J E Schultz1, E Rose, Z Yao, G J Gross.   

Abstract

The purpose of the present study was to investigate a possible role of opioid receptors in ischemic preconditioning (PC). To test this hypothesis, anesthetized, open-chest, male Wistar rats were subjected to five different protocols. In group I, the control group was subjected to 30 min of left coronary artery occlusion and 2 h of reperfusion. In group II, ischemic PC was elicited by three 5-min occlusion periods interspersed with 5 min of reperfusion. In group III, naloxone (NL, 3 mg/kg iv), a nonselective opioid antagonist, was given to nonpreconditioned rats 10 min before the 30-min occlusion period. Finally, NL was administered 10 min before preconditioning (NL + PC, group IV) or immediately after the last 5-min preconditioning period (PC + NL, group V). Infarct size (IS) as a percentage of the area at risk (AAR) (IS/AAR) was determined by 2,3,5-triphenyltetrazolium chloride staining. PC resulted in a marked reduction in myocardial IS from 45 +/- 5 to 8 +/- 1 (P < 0.05). NL treatment before or immediately after PC abolished this protective effect; however, NL had no effect on IS in non-PC rats. These results are the first to support the hypothesis that activation of opioid receptors may play an important role in ischemic PC in the rat myocardium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7771566     DOI: 10.1152/ajpheart.1995.268.5.H2157

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  54 in total

Review 1.  Mechanism of cardioprotection by early ischemic preconditioning.

Authors:  Xiulan Yang; Michael V Cohen; James M Downey
Journal:  Cardiovasc Drugs Ther       Date:  2010-06       Impact factor: 3.727

2.  Opioid receptor agonists activate pertussis toxin-sensitive G proteins and inhibit adenylyl cyclase in canine cardiac sarcolemma.

Authors:  F Niroomand; R A Mura; L Piacentini; W Kübler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

3.  All preconditioning-related G protein-coupled receptors can be demonstrated in the rabbit cardiomyocyte.

Authors:  Wenkuan Xin; Xiulan Yang; Thomas C Rich; Thomas Krieg; Robert Barrington; Michael V Cohen; James M Downey
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011-08-09       Impact factor: 2.457

4.  Featured Article: Pharmacological postconditioning with delta opioid attenuates myocardial reperfusion injury in isolated porcine hearts.

Authors:  Maria Seewald; James A Coles; Daniel C Sigg; Paul A Iaizzo
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

5.  Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels.

Authors:  Garrett J Gross; Anna Hsu; Kasem Nithipatikom; Adam W Pfeiffer; Irina Bobrova; Erik Bissessar
Journal:  Pharmacology       Date:  2012-07-18       Impact factor: 2.547

Review 6.  Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency.

Authors:  Donna H Korzick; Timothy S Lancaster
Journal:  Pflugers Arch       Date:  2013-03-23       Impact factor: 3.657

7.  Adverse cardiac events associated with incident opioid drug use among older adults with COPD.

Authors:  Nicholas T Vozoris; Xuesong Wang; Peter C Austin; Douglas S Lee; Anne L Stephenson; Denis E O'Donnell; Sudeep S Gill; Paula A Rochon
Journal:  Eur J Clin Pharmacol       Date:  2017-06-29       Impact factor: 2.953

Review 8.  Therapeutic receptor targets of ischemic preconditioning.

Authors:  Ryan M Fryer; John A Auchampach; Garrett J Gross
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

9.  Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction.

Authors:  Peter E Penson; William R Ford; Emma J Kidd; Kenneth J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

Review 10.  Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors:  Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal:  World J Diabetes       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.